FABENTECH
General Information
Identification Code: 055505446104-20
Website: [object Object]
Entity Form: French joint-stock company
Registration Category: Companies & groups
Registration Date: 4/12/2022
Last Update: 3/5/2024
EP Accredited Number: 0
Mission & Interests
Goals: FABENTECH is a French biotech company with 14 years of experience in developing and producing emergency treatments for human use against emerging infectious diseases, and for biodefence solutions. The technology is based on a polyclonal antibody platform in-licensed from Sanofi Pasteur. The company owns its high performance proprietary industrial tool making it possible to produce its therapeutic solutions in record time at the EU scale.
In a context of proliferating risks linked to epidemics and biological threats, and faced with the issues of health sovereignty, FABENTECH aims to anticipate risks by producing specific stocks of treatments against emerging and bioterrorist pathogens.
The WHO and the EMA have recognized FABENTECH as the unique European SME able to develop anti-infective passive immunotherapy solutions against major public health and medical emergency threats for which no specific treatment options are available.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Budget
- Public health
- Research and innovation
Levels of Interest:
- european
- sub-national
- national
Activities
Main EU Legislative Proposals: The Covid-19 crisis revealed the low preparedness of nations to face emerging diseases and major public health issues. In a context of increased risk of pandemics and bioterrorist attacks, treatments are lacking, and no relevant therapeutic option can fight the acute symptoms from these new biothreats.
As a biotech company developing and producing treatments in Europe against biothreats. FABENTECH aims to participate to the construction of EU preparedness plans to prevent future pandemics and responses regarding health security.
As a consequence we are interested in policies and decisions including:
- Pandemic preparedness plans and stockpiling strategies organized through DG HERA
- Union Civil Protection Mechanism (rescEU)
- Fundings from European Defence Fund to fund research to develop medical countermeasures against Chemical, Biological, Radiological and Nuclear risks
- Council decisions, EU parliament resolutions and Commission decisions regarding CBRN Action Plan
- Cross-Border Health Threats Regulation
- Strategy and decisions regarding the EU FAB mechanism to support EU sovereignty of the supply chain regarding medical countermeasures and health products.
- European Health Union
- EU Recovery and Resilience Funds
- European Pharmaceutical Strategy
- EU4Health
- Market access strategies from the European Medical Agency regarding emergency treatments in case of outbreaks.
Communication Activities: No communication so far.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 24, rue Jean Baldassini - Bâtiment B
Post Code: 69007
City: Lyon
Country: FRANCE
Phone: [object Object]
EU Office
Address: 24, rue Jean Baldassini - Bâtiment B
Post Code: 69007
City: Lyon
Country: FRANCE
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: As a biotech company we only receive EU grants for résearch and development activities.
Membership Information
Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.25
Info Members: We have a contract with consultants in the field of public affairs starting from march 2022. Those consultants will support company's efforts to communicate with EU bodies and agencies.
The business development manager (25%) and the CEO of the company will be the contacts persons with EU institutions.
Structure
Structure Type: Structure
Is Member Of: NA
Organisation Members: The company has memberships to the following associations:
- France Biotech, the french cluster in biotechnology - https://france-biotech.fr/
- LyonBiopole, the regional cluster in biotechnology - https://lyonbiopole.com/en/
- Mab Design, the french cluster in immunotherapy - https://www.mabdesign.fr/en/